Clinical Trials Browser

Phase 3 × Therapeutic Uses × 90 days × Clear all

NCT06747455 2026-04-27

BCG for Therapeutic Use Phase Ⅲ Clinical Trial

Phase 3 Active not recruiting

Urinary Bladder Neoplasms